Sumitomo Pharma Co., Ltd.
29
1
2
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
13.8%
4 terminated/withdrawn out of 29 trials
85.2%
-1.3% vs industry average
41%
12 trials in Phase 3/4
39%
9 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP
Role: lead
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Role: collaborator
A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan
Role: lead
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Role: collaborator
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
Role: lead
A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease
Role: lead
Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
Role: lead
Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)
Role: lead
A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
Role: lead
A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer
Role: lead
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
Role: lead
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia
Role: lead
A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
Role: lead
A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma
Role: lead
A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
Role: lead
Study of DSP-7888 in Patients With Myelodysplastic Syndrome
Role: lead
DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
Role: lead
Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer
Role: lead
Long-term Study of DSP-5423P in Patients With Schizophrenia
Role: lead
A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma
Role: lead